HomeOCD1 • FRA
add
Niagen Bioscience Inc
Nakaraang pagsara
€6.70
Sakop ng araw
€6.80 - €6.80
Sakop ng taon
€2.24 - €8.35
Market cap
611.12M USD
Average na Volume
44.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 29.12M | 37.41% |
Gastos sa pagpapatakbo | 11.09M | -15.41% |
Net na kita | 7.18M | 6,197.37% |
Net profit margin | 24.65 | 4,464.81% |
Kita sa bawat share | 0.03 | — |
EBITDA | 7.30M | 15,108.33% |
Aktuwal na % ng binabayarang buwis | 4.08% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 44.51M | 63.79% |
Kabuuang asset | 68.28M | 24.22% |
Kabuuang sagutin | 22.18M | -16.31% |
Kabuuang equity | 46.09M | — |
Natitirang share | 77.92M | — |
Presyo para makapag-book | 11.36 | — |
Return on assets | 28.49% | — |
Return on capital | 41.34% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 7.18M | 6,197.37% |
Cash mula sa mga operasyon | 8.58M | 1,222.50% |
Cash mula sa pag-invest | -69.00K | -228.57% |
Cash mula sa financing | 3.75M | 5,031.58% |
Net change in cash | 12.26M | 2,121.38% |
Malayang cash flow | 6.05M | 635.65% |
Tungkol
Niagen Bioscience, formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ. Wikipedia
Itinatag
1999
Headquarters
Website
Mga Empleyado
104
